chalcone has been researched along with Carcinoma, Squamous Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HW; Chen, CS; Chen, SC; Hseu, YC; Liao, JW; Lin, E; Lin, KY; Lin, WH; Wang, L; Wang, SY; Yang, HL | 1 |
Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ | 1 |
Go, ML; Kirk, K; Liu, M; Rosenthal, PJ; Saliba, KJ; Wilairat, P | 1 |
3 other study(ies) available for chalcone and Carcinoma, Squamous Cell
Article | Year |
---|---|
Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Caspase 3; Caspase 8; Caspase 9; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cell Proliferation; Chalcone; Cytochromes c; DNA Fragmentation; Down-Regulation; Female; Flavonoids; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mitochondria; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Urokinase-Type Plasminogen Activator | 2012 |
Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Chalcone; Colonic Neoplasms; Endothelium, Vascular; HCT116 Cells; Humans; Inhibitory Concentration 50; Melanoma; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes.
Topics: Animals; Antimalarials; Carcinoma, Squamous Cell; Cell Line, Tumor; Chalcone; Chemical Phenomena; Chemistry, Physical; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Malaria; Plasmodium falciparum; Sorbitol; Structure-Activity Relationship | 2004 |